1. Home
  2. CRSR vs CMPX Comparison

CRSR vs CMPX Comparison

Compare CRSR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

HOLD

Current Price

$6.18

Market Cap

693.8M

Sector

Technology

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.14

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSR
CMPX
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
693.8M
752.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CRSR
CMPX
Price
$6.18
$5.14
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$9.75
$13.44
AVG Volume (30 Days)
1.1M
2.0M
Earning Date
02-11-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,449,248,000.00
N/A
Revenue This Year
$12.96
N/A
Revenue Next Year
$9.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.79
N/A
52 Week Low
$5.35
$1.33
52 Week High
$13.02
$5.86

Technical Indicators

Market Signals
Indicator
CRSR
CMPX
Relative Strength Index (RSI) 43.16 53.18
Support Level $6.08 $4.83
Resistance Level $6.33 $5.27
Average True Range (ATR) 0.23 0.28
MACD 0.01 -0.06
Stochastic Oscillator 15.08 33.51

Price Performance

Historical Comparison
CRSR
CMPX

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: